|
|
Volumn 8, Issue 2, 2008, Pages 156-171
|
|
Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia
|
|
Author keywords
Alemtuzumab; Apolizumab; BL22; CLL; Denileukin diftitox; Epratuzumab; GA 101; HCD122; HuMax CD20; IMMU 106; LMP 2; Lumiliximab; Ofatumumab; Rituximab; SGN 40
|
|
Indexed keywords
ALEMTUZUMAB;
APOLIZUMAB;
BEVACIZUMAB;
BL 22;
CD20 ANTIGEN;
CD40 MONOCLONAL ANTIBODY;
CD52 ANTIGEN;
CHLORAMBUCIL;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
DENILEUKIN DIFTITOX;
EPRATUZUMAB;
FLUDARABINE;
GA 101;
GALIXIMAB;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HCD 122;
HLA DR ANTIGEN;
IMMU 106;
IMMUNOTOXIN;
IMMUNOTOXIN LMB2;
LUMILIXIMAB;
MONOCLONAL ANTIBODY;
OFATUMUMAB;
PENTOSTATIN;
PURINE NUCLEOSIDE DERIVATIVE;
RITUXIMAB;
SGN 40;
THALIDOMIDE;
UNCLASSIFIED DRUG;
AMINOTRANSFERASE BLOOD LEVEL;
ANTINEOPLASTIC ACTIVITY;
ASEPTIC MENINGITIS;
ASTHENIA;
AUTOIMMUNE DISEASE;
BLOOD TOXICITY;
BRONCHOSPASM;
CARDIOMYOPATHY;
CHILL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
CONSTIPATION;
COUGHING;
CYTOPENIA;
DIARRHEA;
DRUG DOSE ESCALATION;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EDEMA;
FATIGUE;
FEVER;
HEADACHE;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HYPERTENSION;
HYPOALBUMINEMIA;
HYPONATREMIA;
HYPOTENSION;
INFECTION;
LEUKOPENIA;
LOADING DRUG DOSE;
LYMPHOCYTOPENIA;
MALAISE;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PULMONARY HYPERTENSION;
REVIEW;
RIGOR;
SEPSIS;
SIDE EFFECT;
THROMBOCYTOPENIA;
TRANSAMINASEMIA;
UNSPECIFIED SIDE EFFECT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
|
|
EID: 40449108219
PISSN: 15680096
EISSN: None
Source Type: Journal
DOI: 10.2174/156800908783769319 Document Type: Review |
|
Times cited : (43)
|
|
References (134)
|
